Toirac LA, Pascual LV, Blanco RG

Language: Spanish
References: 16
Page: 1195-1206
PDF size: 390.13 Kb.

ABSTRACT

A longitudinal and prospective case-control study was carried out in "Tamara Bunke Bider" Gyneco-obstetric Teaching Hospital of Santiago de Cuba, during a period of 8 years, in order to characterize the pregnant woman or puerpera with some heart disease to achieve a differentiated care, adjusted to an interdisciplinary and comprehensive care protocol, designed from previous experience gained in other patients with high risk. One hundred and thirteen pregnant women with clinical diagnosis and paraclinical confirmation of heart disease (cases) were divided into groups and 226 (control) were selected from a total of 25 412 no cardiac pregnant women. The classification was performed by means of anatomical criteria of Carrera-Macías, functional assessment of New York Heart Association, the levels of risk of cardiac death of Clark and, finally, the type-categories raised by this working group for this purpose. The results are certainly satisfactory and encouraging, with the aforementioned comprehensive obstetric and perinatal treatment and necessary cardiac and cardiosurgical care offered by the Heart Center of "Saturnino Lora Torres" Clinical Surgical Teaching Hospital of this province..

REFERENCES

1. Pijuan Domenech A, Gatzoulis MA. Embarazo y cardiopatía. Rev Esp Cardiol. 2006; 59(9): 971-84.

2. Da Graca LM, Lopo TM. Cardiopatías y gravidez. En: Mendes da Graca L. Medicina materno-fetal. 3 ed. Lisboa: Lidel; 2005: V2. p. 537-52.

3. Cunningham FG, Leveno KJ, Bloom SL, Haut JC, Rouse DJ, Spong CY. Williams Obstetrics. 23 ed. Cardiovascular disease. New York: The McGraw-Hill Companies; 2010.

4. Kung HC, Hoyert DL, Xu J, Murphy SL. Deaths: final data for 2005. Natl Vital Stat Rep. 2008; 56(10): 1-120.

5. López Escobar G. Algunos aspectos de las cardiopatías y la mecánica circulatoria durante el embarazo. Rev Colomb Obstet Ginecol. 2000; 51(2): 17-37.

6. Parlakhumus HA, Haydardedeoglu B. A review of cardiovascular complications of pregnancy. Gynecol Pol. 2010; 81(4): 292-7.

7. Dolk H, Loane M, Garne E. The prevalence of congenital anormalies in Europe. Adv Exp Med Biol. 2010; 686: 349-64.

8. Harris IS. Management of pregnancy in patients with congenital heart disease. Prog Cardiovasc Dis. 2011; 53(4): 305-11.

9. Barth WH. Cardiac surgery in pregnancy. Clin Obstet Gynecol. 2009; 52(4): 630-46.

10. Siu SC, Sermer M, Colman JM, Alvarez N, Mercier L, Morton B, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation. 2001; 104(5): 515-21.

11. Liu H, Xu JW, Zhao XD, Ye TY, Lin JH, Lin QD. Pregnancy outcomes in women with heart disease. Chin Med J. 2010; 123(17): 2324-30.

12. Braunwald E. Valvular heart disease. En: Kasper DL, Braunwald E, Fauci AS. Harrison's principles of internal medicine. 16 ed. New York: McGraw Hill; 2005. p. 1390.

13. Bates SM, Greer IA, Pabinger I, Sofaer S, Hirsh J. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American Collage of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest. 2008; 133(6 Suppl): 844-86.

14. Butchard EG, Gohlke-Barwolf C, Antunes MJ, Tornos P, De Caterina R, Cormier B, et al. Recommendations for the management of patients after heart valve surgery. Eur Heart J. 2005; 26(22): 2463-2471.

15. American College of Obstetricians and Gynecologists Committee on Obstetric Practice. ACOG Committee Opinion No. 421, November 2008: antibiotic prophylaxis for infective endocarditis. Obstet Gynecol. 2008; 112(5): 1193-4.

16. Gilbert DN, Moellering RC, Eliopoulos GM, Cambers HF, Saag, MS. The SANFORD Guide to Antimicrobial Therapy. 41 ed. Sperryville 2011. Page 181; Table 15C-Antimicrobial prophylaxis for the prevention of bacterial Endocarditis in patients underlying cardiac conditions. Antimicrobial Therapy, Inc., VA, USA.